Advertisement

An extensive nodular lesion involving hard palate and nasal turbinate

      A 38-year-old man was referred to our institute for the examination of asymptomatic swelling on the right posterolateral aspect of the hard palate. The patient noticed the swelling 2 months before when it increased to its present size and was perceived during tongue movement. The patient's medical, social, and dental history were nonsignificant. To the best of his knowledge, he was not allergic to any medication and did not undergo any prior surgery. He did not consume tobacco products or have a history of any parafunctional habit or trauma.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      References

        • Toida M
        • Shimokawa K
        • Makita H
        • et al.
        Intraoral minor salivary gland tumors: a clinicopathological study of 82 cases.
        Int J Oral Maxillofac Surg. 2005; 34: 528-532
        • Almeslet AS.
        Pleomorphic adenoma: a systematic review.
        Int J Clin Pediatr Dent. 2020; 13: 284-287
        • Bavle RM.
        Microcalcifications in salivary gland tumors.
        J Oral Maxillofac Pathol. 2014; 18: 2-3
        • González-Arriagada WA
        • Santos-Silva AR
        • Ito FA
        • Vargas PA
        • Lopes MA.
        Calcifications may be a frequent finding in mucoepidermoid carcinomas of the salivary glands: a clinicopathologic study.
        Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011; 111: 482-485
        • Silva TD
        • Ferreira CB
        • Leite GB
        • de Menezes Pontes JR
        • Antunes HS.
        Oral manifestations of lymphoma: a systematic review.
        Ecancermedicalscience. 2016; 10: 665
        • Abdelwahed Hussein MR
        Non-Hodgkin's lymphoma of the oral cavity and maxillofacial region: a pathologist viewpoint.
        Expert Rev Hematol. 2018; 11: 737-748
        • Krishnamurthy A
        • Palaniappan R.
        Osteosarcomas of the head and neck region: a case series with a review of literature.
        J Maxillofac Oral Surg. 2018; 17: 38-43
        • Bertin H
        • Gomez-Brouchet A
        • Rédini F.
        Osteosarcoma of the jaws: an overview of the pathophysiological mechanisms.
        Crit Rev Oncol Hematol. 2020; 156103126
        • ElKordy MA
        • ElBaradie TS
        • ElSebai HI
        • KhairAlla SM
        • Amin AAE.
        Osteosarcoma of the jaw: challenges in the diagnosis and treatment.
        J Egypt Natl Canc Inst. 2018; 30: 7-11
        • Weiss SW
        • Goldblum JR
        • Folpe AL.
        Cartilaginous and osseous soft tissue tumors.
        In: Weiss SW, Goldblum JR, Folpe AL, editors. Enzinger and Weiss's soft tissue tumors. Elsevier health sciences, North York2020: 1053-1062
        • de Souza LL
        • Pontes FS
        • Fonseca FP
        • da Mata Rezende DS
        • Vasconcelos VCS
        • Pontes HAR.
        Chondrosarcoma of the jaw bones: a review of 224 cases reported to date and an analysis of prognostic factors.
        Int J Oral Maxillofac Surg. 2019; 48: 452-460
        • Stanbouly D
        • Litman E
        • Vasilyeva D
        • Philipone E.
        Mesenchymal chondrosarcoma in the maxilla: a case report and literature review.
        J Oral Maxillofac Surg. 2021; 79: 1706-1711
        • Margaix-Muñoz M
        • Bagán J
        • Poveda-Roda R.
        Ewing sarcoma of the oral cavity. A review.
        J Clin Exp Dent. 2017; 9: e294-e301
        • Murphey MD
        • Senchak LT
        • Mambalam PK
        • Logie CI
        • Klassen-Fischer MK
        • Kransdorf MJ.
        From the radiologic pathology archives: Ewing sarcoma family of tumors: radiologic-pathologic correlation.
        Radiographics. 2013; 33: 803-831
        • Pasello M
        • Manara MC
        • Scotlandi K.
        CD99 at the crossroads of physiology and pathology.
        J Cell Commun Signal. 2018; 12: 55-68
        • Yoshida A
        • Sekine S
        • Tsuta K
        • Fukayama M
        • Furuta K
        • Tsuda H.
        NKX2. 2 is a useful immunohistochemical marker for Ewing sarcoma.
        Am J Surg Pathol. 2012; 36: 993-999
        • Takata T
        • Slootweg PJ.
        Odontogenic and maxillofacial bone tumours.
        in: El Naggar AK Chan JK Grandis JR Takata T Slootweg PJ WHO Classification of Head and Neck Tumours. 4th ed. IARC, Lyon: France2017: 203-232
        • Vencio EF
        • Reeve CM
        • Unni KK
        • Nascimento AG.
        Mesenchymal chondrosarcoma of the jaw bones: clinicopathologic study of 19 cases.
        Cancer. 1998; 82: 2350-2355
        • Almansoori AA
        • Kim HY
        • Kim B
        • Kim SM
        • Lee JH.
        Chondrosarcoma of the jaw: a retrospective series.
        Oral Surg Oral Med Oral Pathol Oral Radiol. 2019; 128: 106-111
        • Takahashi K
        • Sato K
        • Kanazawa H
        • Wang XL
        • Kimura T.
        Mesenchymal chondrosarcoma of the jaw – report of a case and review of 41 cases in the literature.
        Head Neck. 1993; 15: 459-464
        • Reeh MJ.
        Hemangiopericytoma with cartilaginous differentiation involving orbit.
        Arch Ophthalmol. 1966; 75: 82-83
        • Choo CS
        • Wan Abdul Rahman WF
        • Jaafar H
        • Ramli RR
        Mesenchymal chondrosarcoma of maxilla in paediatric patient.
        BMJ Case Rep. 2019; 12e228969
        • Shibuya R
        • Matsuyama A
        • Nakamoto M
        • Shiba E
        • Kasai T
        • Hisaoka M.
        The combination of CD99 and NKX2.2, a transcriptional target of EWSR1-FLI1, is highly specific for the diagnosis of Ewing sarcoma.
        Virchows Arch. 2014; 465: 599-605
        • Wehrli BM
        • Huang W
        • De Crombrugghe B
        • Ayala AG
        • Czerniak B.
        Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors.
        Hum Pathol. 2003; 34: 263-269
        • Wang L
        • Motoi T
        • Khanin R
        • et al.
        Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
        Genes Chromosomes Cancer. 2012; 51: 127-139
        • Folpe AL
        • Graham RP
        • Martinez A
        • Schembri-Wismayer D
        • Boland J
        • Fritchie KJ.
        Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.
        Hum Pathol. 2018; 77: 28-34
        • Schneiderman BA
        • Kliethermes SA
        • Nystrom LM.
        Survival in mesenchymal chondrosarcoma varies based on age and tumor location: a survival analysis of the SEER database.
        Clin Orthop Relat Res. 2017; 475: 799-805